The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Recurrence-free survival as a surrogate endpoint for overall survival in resectable esophageal cancer: An individual patient data analysis of phase III RCTs.
 
Jun Okui
Employment - Sumitomo Pharma Co., Ltd. (I)
 
Satoru Matsuda
Honoraria - Chugai Pharma; Covidien/Medtronic; Daiichi Sankyo/Lilly; Ethicon; MSD; Olympus Medical Systems; Ono Pharmaceutical
 
Kengo Nagashima
Consulting or Advisory Role - Kowa; Lilly (Inst); Senju Pharmaceutical; Toray Industries
 
Yasunori Sato
Honoraria - Lilly Japan
Consulting or Advisory Role - Mochida Pharmaceutical Co. Ltd.
 
Hirofumi Kawakubo
No Relationships to Disclose
 
Thomas Ruhstaller
Honoraria - Lilly, Novartis, Daiichi Sankyo/Lilly
Consulting or Advisory Role - Novartis, Roche, AstraZeneca, Lilly
Expert Testimony - Novartis, Lilly
 
Peter Thuss-Patience
Consulting or Advisory Role - Bristol-Myers Squibb, Merck Serono, Lilly, Novartis, Pfizer, Roche, AstraZeneca, Daiichi Sankyo, Astellas Pharma, MSD, SERVIER
Research Funding - Merck/Pfizer (Inst)
Travel, Accommodations, Expenses - Merck Serono, AstraZeneca
 
Magnus Nilsson
Travel, Accommodations, Expenses - Medtronic
 
Fredrik Klevebro
No Relationships to Disclose
 
Lijie Tan
No Relationships to Disclose
 
Shaoyuan Zhang
No Relationships to Disclose
 
Thomas Aparicio
Honoraria - MSD; Pierre Fabre; Takeda
Consulting or Advisory Role - Bayer; Bristol Myers Squibb; Pierre Fabre
Travel, Accommodations, Expenses - Amgen; BMS; MSD Oncology; Pierre fabre; SERVIER
 
Guillaume Piessen
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Elivie; MSD Oncology; Nestle health science; Stryker
Travel, Accommodations, Expenses - Elivie; medtronic; MSD Oncology
Other Relationship - elivie
(OPTIONAL) Uncompensated Relationships - Medtronic
 
Charlène van der Zijden
No Relationships to Disclose
 
Bianca Mostert
Consulting or Advisory Role - BMS, Astra Zeneca, Amgen
Research Funding - Bristol-Myers Squibb
 
Bas Wijnhoven
Consulting or Advisory Role - BMS
Research Funding - BMS
 
Takahiro Tsushima
Honoraria - Bristol-Myers Squibb Japan; MSD; Ono Pharmaceutical; Taiho Pharmaceutical
 
Hiroya Takeuchi
Honoraria - Bristol-Myers Squibb Japan; Daiichi Sankyo/Astra Zeneca; EA Pharma; Intuitive Surgical; Johnson & Johnson/MedTech; Kaken Pharmaceutical; Medicon; Medtronic; Miyarisan pharmaceutical; MSD K.K; Nihonkayaku; Novartis; Olympus Medical Systems; Ono Pharmaceutical; Otsuka; Sysmex; Taiho Pharmaceutical; Tsumura & Co.
Research Funding - Chugai Pharma (Inst); Kaken Pharmaceutical (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Tanabe Mitsubishi Pharmaceutical (Inst)
 
Ken Kato
Honoraria - BMS; Lilly; Ono Pharmaceutical
Consulting or Advisory Role - AstraZeneca; BeiGene; Chugai Pharma; Daiichi Sankyo/UCB Japan; MSD; Oncolys BioPharma; Ono Pharmaceutical
Speakers' Bureau - Bristol-Myers Squibb Japan; MSD; Ono Pharmaceutical
Research Funding - AstraZeneca (Inst); Beigene (Inst); Chugai Pharma (Inst); Daiichi Sankyo/UCB Japan (Inst); MSD Oncology (Inst); Ono Pharmaceutical (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst)
 
Yuko Kitagawa
Honoraria - Asahi Kasei; ASKA Pharmaceutical Co., Ltd.; Astellas Pharma; AstraZeneca Japan; Bristol-Myers Squibb K.K.; Chugai Foundation for Innovative Drug Discovery Science; Chugai Pharma; DAIICHI SANKYO COMPANY, LIMITED; EA Pharma; Eisai; Ethicon; Intuitive Surgical; Japan Lifeline Co.,Ltd.; Kaken Pharmaceutical; Kowa; Miyarisan pharmaceutical; MSD K.K.; Nippon Covidien; Nippon Kayaku; Olympus; Ono Pharmaceutical; Otsuka; Shionogi; Smart Hospital Inc.; Sysmex; T-PEC CORPORATION; Taiho Pharmaceutical; Takeda; Toray Industries; TSUMURA & CO.
Consulting or Advisory Role - Bristol-Myers Squibb K.K.; Ono Pharmaceutical
Research Funding - Asahi Kasei (Inst); Chugai Pharma (Inst); Eisai (Inst); Kaken Pharmaceutical (Inst); Kowa (Inst); Kyouwa Hakkou Kirin Co., Ltd. (Inst); Nippon Covidien (Inst); Otsuka (Inst); Otsuka (Inst); Sumitomo Pharma Co., Ltd. (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Teijin Pharma (Inst); TSUMURA & CO. (Inst)